The company will finalise the IPO share allotment by June 17. The trading in its equity shares will commence on the NSE ...

Cancer diagnostic firm Caris Life Sciences on Monday raised the proposed price range for its New York initial public offering, targeting a valuation of up to $5.67 billion and indicating a strong ...